Prof. Xu Xiaochun from the Institute of Molecular Medicine, Peking University, at the invitation of Prof. Du Fuliang from Jiangsu Key Laboratory for Molecular and Medical Biotechnology and Laboratory of Transformation Genomics and Embryo Engineering in School of Life Sciences of NNU, will deliver a report for academic visit and exchanges on 16 June 2016.
Title of the report: Stem Cell Technology: Past, Present and Future）
Time：1:30P.M~2:45P.M on June 16, 2016 (Thursday)
Location: Round meeting room of School of Life Sciences, 3rd floor
Professor of the Institute of Molecular Medicine, Peking University, Director-general of PKU•Boya Cooperative Translation Medicine Center, and Chairman of BoyaLife Group
Prof. Xu Xiaochun gained the PhD in immunology from School of Medicine of Washington University and Executive MBA from Business School of Emory University. He was employed by Pfizer and the Institute of Medicine of Founder. He is the Chairman of BoyaLife Group and Director-general of PKU•Boya Cooperative Translation Medicine Center. He has published over 40 articles, reviews and textbooks and has been invited to speak at the international conferences over 20 times. He won the medical research award of international professional organization six times. Prof. Xu has gained the honor of “Innovation and Entrepreneurship Talent Award in Jiangsu Province” and "China 100 New Returned Entrepreneurs", and he was selected as one of the Economic Figures for 2013 by People Daily and Economic Daily.
Since the 21st century, life science and technology is developing at an unprecedented speed and the world is entering a new era of industrial revolution with life science and technology as the pillar. In the next decade (2015-2025), life science industry with genetic diagnosis and engineering, new types of vaccines, tissue engineering, stem cell and cloning technology, biological information, and accurate medical technology as the core, is expected to develop at a very high speed. Stem cell technology is one of the most promising technologies in the field of life science and clinical medicine. The most prominent feature of stem cell technology is its ability to regenerate new or even younger cells, tissue or organ. People can use their own or someone else’s stem cell to replace the diseased or aging tissue and it can be widely applied in the treatment of various chronic diseases that traditional medical treatment methods are unable to cure. Over the past 60 years, stem cell technology has changed. Personalized medicine represented by stem cell technology will become a core technology influencing the future of clinical medicine, and lead to a revolution in medical and life science.